Education
About Us
Working with TipRanks
Follow Us
Orchid Pharma Limited (IN:ORCHPHARMA)
:ORCHPHARMA
Total Valuation
Orchid Pharma Limited has a market cap or net worth of ₹35.05B. The enterprise value is ₹14.28B.
Market Cap₹35.05B
Enterprise Value₹14.28B
Share Statistics
Orchid Pharma Limited has 50,719,105 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding50,719,105
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Orchid Pharma Limited’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 17.80%.
Return on Equity (ROE)0.08
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)17.80%
Return on Capital Employed (ROCE)0.18
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.55
Inventory Turnover1.67
Valuation Ratios
The current PE Ratio of Orchid Pharma Limited is 39.84. Orchid Pharma Limited’s PEG ratio is -0.02.
PE Ratio39.84
PS Ratio0.00
PB Ratio-0.23
Price to Fair Value3.13
Price to FCF29.67
Price to Operating Cash Flow13.32
PEG Ratio-0.02
Income Statement
In the last 12 months, Orchid Pharma Limited had revenue of 9.22B and earned 996.57M in profits. Earnings per share was 19.65.
Revenue9.22B
Gross Profit3.78B
Operating Income2.57B
Pretax Income955.65M
Net Income996.57M
EBITDA1.45B
Earnings Per Share (EPS)19.65
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Orchid Pharma Limited pays an annual dividend of ₹3, resulting in a dividend yield of ―
Dividend Per Share₹3
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.40
52-Week Price Change-39.87%
50-Day Moving Average747.51
200-Day Moving Average1.21K
Relative Strength Index (RSI)41.26
Average Volume (3m)16.69K
Important Dates
Orchid Pharma Limited upcoming earnings date is Aug 7, 2025, TBA Not Confirmed.
Last Earnings DateMay 26, 2025
Next Earnings DateAug 7, 2025
Ex-Dividend DateSep 13, 2012
Financial Position
Orchid Pharma Limited as a current ratio of 2.83, with Debt / Equity ratio of -458.78%
Current Ratio2.83
Quick Ratio1.68
Debt to Market Cap0.04
Net Debt to EBITDA1.06
Interest Coverage Ratio17.66
Taxes
In the past 12 months, Orchid Pharma Limited has paid -1.94M in taxes.
Income Tax-1.94M
Effective Tax Rate>-0.01
Enterprise Valuation
Orchid Pharma Limited EV to EBITDA ratio is 28.51, with an EV/FCF ratio of -31.51.
EV to Sales4.47
EV to EBITDA28.51
EV to Free Cash Flow-31.51
EV to Operating Cash Flow214.63
Balance Sheet
Orchid Pharma Limited has ₹2.44B in cash and marketable securities with ₹0.00 in debt, giving a net cash position of -₹2.44B billion.
Cash & Marketable Securities₹2.44B
Total Debt₹0.00
Net Cash-₹2.44B
Net Cash Per Share-₹48.09
Tangible Book Value Per Share₹246.52
Margins
Gross margin is 48.14%, with operating margin of 27.85%, and net profit margin of 10.81%.
Gross Margin48.14%
Operating Margin27.85%
Pretax Margin10.37%
Net Profit Margin10.81%
EBITDA Margin15.69%
EBIT Margin11.94%
Analyst Forecast
The average price target for Orchid Pharma Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―